Fresenius Medical Care AG (FME.DE)
| Previous close | 37.43 |
| Open | 37.92 |
| Bid | 38.56 x 38700 |
| Ask | 38.60 x 105300 |
| Day's range | 37.92 - 39.02 |
| 52-week range | 30.16 - 49.62 |
| Volume | |
| Avg. volume | 467,651 |
| Market cap | 11.317B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 23.38 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.19 (3.18%) |
| Ex-dividend date | 17 May 2024 |
| 1y target est | N/A |
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
- Simply Wall St.
Fresenius Medical Care First Quarter 2024 Earnings: EPS Beats Expectations
Fresenius Medical Care ( ETR:FME ) First Quarter 2024 Results Key Financial Results Revenue: €4.73b (flat on 1Q 2023...
- Zacks
Will These 5 Medical Device Stocks Beat This Earnings Season?
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
